申请人:Alkermes, Inc.
公开号:US20220194926A1
公开(公告)日:2022-06-23
The present invention provides compounds useful for the treatment of narcolepsy or cataplexy in a subject in need thereof. Related pharmaceutical compositions and methods are also provided herein.
本发明提供了一种用于治疗需要治疗嗜睡症或弛缓症患者的化合物。此外,还提供了相关的制药组合物和方法。